Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. is projected to experience solid financial growth, with an estimated 6.7% year-over-year normalized Funds From Operations per share (FFOps) growth in 2025, followed by 2.9% growth in 2026. Additionally, there is an encouraging forecast of 7.9% annual FFOps growth over the next five years, supported by rising rents associated with upcoming lease expirations and a robust pipeline of investment opportunities. Despite some short-term challenges in same-store SHOP performance, the underlying fundamentals remain strong, positioning the company for future success.

Bears say

National Health Investors Inc faces potential underperformance due to the uncertainty surrounding the NHC rent reset, which could be lower than investor expectations, impacting revenue projections. Additionally, concerns over deferred rent collections and the financial stability of operators, particularly in light of potential future pandemics or operational challenges, further exacerbate risks to the company's outlook. Furthermore, the adjustments to the funds from operations (FFO) estimates reflect a trend of conservative net investment assumptions, with a projected decline in 2026 FFO estimates, indicating weakening financial performance relative to prior forecasts.

NHI has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 4 analysts, NHI has a Buy consensus rating as of Apr 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.